P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
0.197
+0.009 (4.72%)
At close: Dec 20, 2024, 4:00 PM
0.209
+0.012 (6.13%)
After-hours: Dec 20, 2024, 7:57 PM EST
Company Description
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States.
It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
P3 Health Partners Inc.
| Country | United States |
| Founded | 2015 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 400 |
| CEO | Aric Coffman |
Contact Details
Address: 2370 Corporate Circle, Suite 300 Henderson, Nevada 89074 United States | |
| Phone | 702 910 3950 |
| Website | p3hp.org |
Stock Details
| Ticker Symbol | PIII |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001832511 |
| CUSIP Number | 744413105 |
| ISIN Number | US7444131053 |
| Employer ID | 85-2992794 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Dr. Aric Coffman M.D. | Chief Executive Officer and President |
| Dr. Sherif Abdou F.A.C.E.P., FACP, M.D. | Co-Founder, Vice Chairperson of the Board and Strategic Advisor |
| Dr. Amir Bacchus M.B.A., M.D. | Co-Founder, Chief Medical Officer and Director |
| Leif Pedersen | Chief Financial Officer |
| William Bettermann | Executive Vice President and Chief Operating Officer |
| Devery Goodey | Senior Vice President of Technology |
| Sarah Bussmann B.S.N., CRNI, M.H.A., R.N. | Chief Administrative Officer |
| Roy Youngblood | Senior Director of Compliance |
| Leslie P. Fisher | Senior Vice President of Legal Affairs, General Counsel and Corporate Secretary |
| Kassi Belz APR | Executive Vice President of Communications, Culture and Engagement |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 17, 2024 | 8-K | Current Report |
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 8, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Aug 29, 2024 | 8-K | Current Report |
| Aug 7, 2024 | 10-Q | Quarterly Report |
| Aug 7, 2024 | 8-K | Current Report |
| Jun 28, 2024 | 424B3 | Prospectus |
| Jun 27, 2024 | EFFECT | Notice of Effectiveness |